Weiping Jia Selected Research

Fibroblast Growth Factors (Fibroblast Growth Factor)

1/2022	Effects of Exercise Intervention on Type 2 Diabetes Patients With Abdominal Obesity and Low Thigh Circumference (EXTEND): Study Protocol for a Randomized Controlled Trial.
1/2021	FGF21/adiponectin ratio predicts deterioration in glycemia: a 4.6-year prospective study in China.
1/2017	Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.
1/2013	Serum levels of fibroblast growth factor 19 are inversely associated with coronary artery disease in chinese individuals.
6/2009	Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiping Jia Research Topics

Disease

171	Type 2 Diabetes Mellitus (MODY) 04/2024 - 05/2002
68	Insulin Resistance 01/2024 - 05/2002
54	Obesity 02/2024 - 12/2002
29	Non-alcoholic Fatty Liver Disease 11/2023 - 02/2008
22	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 06/2009
21	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2021 - 03/2010
19	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023 - 02/2009
18	Inflammation (Inflammations) 02/2024 - 01/2011
18	Hyperglycemia 09/2020 - 05/2008
17	Atherosclerosis 01/2020 - 04/2011
14	Body Weight (Weight, Body) 10/2023 - 04/2009
14	Diabetes Complications 01/2022 - 11/2008
13	Neoplasms (Cancer) 12/2023 - 01/2012
13	Glucose Intolerance 01/2021 - 06/2009
12	Weight Loss (Weight Reduction) 02/2024 - 01/2013
12	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2023 - 03/2012
11	Overweight 02/2024 - 11/2008
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 04/2011
11	Albuminuria 01/2018 - 12/2009
9	Hypoglycemia (Reactive Hypoglycemia) 12/2023 - 03/2012
9	Diabetes Mellitus 01/2021 - 06/2009
9	Hypertension (High Blood Pressure) 11/2014 - 05/2011
8	Dyslipidemias (Dyslipidemia) 05/2023 - 04/2009
8	Prediabetic State (Prediabetes) 01/2022 - 03/2010
7	Abdominal Obesity 03/2023 - 05/2013
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 01/2017
5	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2023 - 06/2013
5	Metabolic Diseases (Metabolic Disease) 10/2022 - 03/2013
5	Wounds and Injuries (Trauma) 12/2020 - 05/2012
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2017 - 11/2014
4	Fatty Liver 11/2022 - 01/2011
4	Weight Gain 01/2022 - 01/2017
4	Carcinogenesis 08/2019 - 01/2017
4	Liver Cirrhosis (Hepatic Cirrhosis) 11/2018 - 06/2015
4	Chronic Renal Insufficiency 07/2015 - 12/2009
3	COVID-19 03/2024 - 08/2020
3	Carotid Artery Diseases 01/2020 - 01/2012

Drug/Important Bio-Agent (IBA)

107	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 05/2002
43	Insulin (Novolin)FDA Link 12/2023 - 05/2002
24	Biomarkers (Surrogate Marker)IBA 08/2021 - 11/2010
23	fibroblast growth factor 21IBA 01/2022 - 06/2009
22	LipidsIBA 02/2024 - 04/2009
20	Blood Glucose (Blood Sugar)IBA 04/2024 - 11/2008
19	Triglycerides (Triacylglycerol)IBA 01/2023 - 09/2006
15	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2008
13	AlbuminsIBA 10/2023 - 12/2009
12	OsteocalcinIBA 01/2022 - 11/2009
11	Fatty Acid-Binding ProteinsIBA 01/2022 - 01/2011
11	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 03/2012
10	CreatinineIBA 10/2023 - 12/2009
9	Bile Acids and Salts (Bile Acids)IBA 02/2024 - 04/2016
9	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 03/2012
9	Indicators and Reagents (Reagents)IBA 02/2021 - 03/2010
8	Hypoglycemic Agents (Hypoglycemics)IBA 12/2023 - 04/2012
8	LDL CholesterolIBA 03/2023 - 01/2014
8	Uric Acid (Urate)IBA 01/2017 - 03/2012
7	AdipokinesIBA 11/2023 - 08/2007
7	EnzymesIBA 01/2022 - 12/2002
7	Hemoglobins (Hemoglobin)IBA 07/2017 - 05/2012
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2024 - 01/2015
6	oxidized low density lipoproteinIBA 01/2021 - 07/2012
6	Streptozocin (Streptozotocin)FDA Link 01/2019 - 08/2010
6	HDL CholesterolIBA 01/2019 - 07/2012
6	C-PeptideIBA 01/2017 - 02/2011
5	AntigensIBA 01/2023 - 01/2012
5	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 06/2009
5	Lipocalin-2IBA 01/2022 - 12/2013
5	Insulin Glargine (Lantus)FDA Link 01/2022 - 04/2012
5	AdiponectinIBA 01/2022 - 02/2008
5	NAD (NADH)IBA 01/2021 - 11/2014
5	CholesterolIBA 01/2019 - 03/2010
5	hydroxide ionIBA 01/2017 - 01/2012
5	Nonesterified Fatty Acids (NEFA)IBA 04/2016 - 01/2013
5	Cystatin CIBA 01/2016 - 01/2013
5	C-Reactive ProteinIBA 01/2016 - 06/2009
5	CarbohydratesIBA 02/2015 - 04/2009
4	chiglitazarIBA 01/2024 - 01/2021
4	Sitagliptin Phosphate (Januvia)FDA Link 11/2023 - 01/2015
4	CytokinesIBA 01/2022 - 07/2012
4	Acarbose FDA LinkGeneric 01/2021 - 06/2013
4	Retinaldehyde (Retinal)IBA 01/2021 - 03/2012
4	Alanine Transaminase (SGPT)IBA 11/2020 - 01/2013
4	Messenger RNA (mRNA)IBA 06/2020 - 04/2009
4	Amino Acids FDA Link 01/2020 - 04/2009
4	Fibroblast Growth Factor-23IBA 01/2018 - 11/2015
4	ORALIT (ORS)IBA 11/2017 - 11/2008
4	Hormones (Hormone)IBA 08/2016 - 06/2009
4	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2015 - 08/2007
3	Dextrans (Dextran)FDA Link 12/2023 - 06/2023
3	Fenofibrate (CiL)FDA LinkGeneric 07/2021 - 04/2009
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2020 - 02/2011
3	Superoxide DismutaseIBA 06/2020 - 02/2009
3	HaptoglobinsIBA 11/2019 - 01/2018
3	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2019 - 05/2016

Therapy/Procedure

22	Therapeutics 08/2021 - 03/2007
19	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2024 - 11/2014
16	Glycemic Control 01/2024 - 03/2012
10	Bariatric Surgery 01/2021 - 01/2015
4	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 06/2021 - 01/2013
3	Precision Medicine 08/2021 - 03/2013